Riverpoint Wealth Management Holdings, LLC Abbott Laboratories Transaction History

Riverpoint Wealth Management Holdings, LLC

$360 Million
Q2 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $1,095 - $1,209	10 Added 0.51%	1,964 $223,000
Q4 2023 Feb 05, 2024	BUY	$90.19 - $110.4 $176,231 - $215,721	1,954 New	1,954 $215,000
Q2 2023 Aug 07, 2023	BUY	$100.78 - $112.29 $195,009 - $217,281	1,935 New	1,935 $210,000
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $182,230 - $213,783	1,917 New	1,917 $210,000

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

Vanguard Group Inc Valley Forge, PA

166M
Shares

$18.8 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$14.8 Billion
0.31% of portfolio
State Street Corp Boston, MA

74.4M
Shares

$8.41 Billion
0.34% of portfolio
Capital International Investors Los Angeles, CA

71.8M
Shares

$8.12 Billion
1.57% of portfolio
Capital Research Global Investors Los Angeles, CA

57.2M
Shares

$6.47 Billion
1.34% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverpoint Wealth Management Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverpoint Wealth Management Holdings, LLC with notifications on news.

Account